Chemoinformaics analysis of S-allylmercapto-L-cysteine
| Molecular Weight | 193.293 | nRot | 6 |
| Heavy Atom Molecular Weight | 182.205 | nRig | 2 |
| Exact Molecular Weight | 193.023 | nRing | 0 |
| Solubility: LogS | -2.725 | nHRing | 0 |
| Solubility: LogP | -2.035 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 25.8587 |
| nHD | 1 | BPOL | 14.0913 |
| QED | 0.374 |
| Synth | 3.651 |
| Natural Product Likeliness | 1.543 |
| NR-PPAR-gamma | 0.267 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.01 |
| CACO-2 | -5.355 |
| MDCK | 0.0000102 |
| BBB | 0.584 |
| PPB | 0.449535 |
| VDSS | 0.441 |
| FU | 0.355517 |
| CYP1A2-inh | 0.02 |
| CYP1A2-sub | 0.088 |
| CYP2c19-inh | 0.045 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.089 |
| CYP2c9-sub | 0.524 |
| CYP2d6-inh | 0.029 |
| CYP2d6-sub | 0.375 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.072 |
| CL | 12.136 |
| T12 | 0.774 |
| hERG | 0.018 |
| Ames | 0.256 |
| ROA | 0.722 |
| SkinSen | 0.747 |
| Carcinogencity | 0.275 |
| EI | 0.2 |
| Respiratory | 0.913 |
| NR-Aromatase | 0.027 |
| Antiviral | No |
| Prediction | 0.930126 |